Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Top 10 questions about breast cancer answered

2.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

3.

Even a few mutated cells can significantly impact how blood cancers develop, study finds

4.

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

5.

Year in Review: Non-Small Cell Lung Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot